Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
McMaster University
$105,000.00
Dissecting RNA binding protein-directed control over hematopoietic stem cells by CRISPR-based genetic screening
FY 2017-18
Summary
Hematopoietic stem cells (HSCs) maintain an individual's life-time requirement of all the cells that compose the blood system. To achieve this HSCs must balance multiple functions, including the generation of functional blood and immune cells in appropriate frequencies and the enduring potential to recreate identical versions of itself (self-renew). Dysregulation of the balance that defines the HSC program largely underlies cancerous and non-cancerous blood pathologies. Often, HSC transplants are required, life-saving therapies. The success of transplants is limited by the scarcity of HSCs in donor bone marrow samples. As such, a major goal has been to expand functional HSCs prior to transplant. This has proven challenging due to our very limited understanding of the genetic and molecular mechanisms that control the HSC program. Molecular mechanisms depend on the molecules that exist and cooperate within a cell. Notably, genes in a cell are first turned on in the form of RNA molecules that undergo many decisions before they are turned into a final product, often a protein molecule. To date, much effort has been directed to understanding the first step when genes are turned on (transcribed) in HSCs. By contrast, very little is known of the specific decisions made to generate the final products in HSCs, a process termed post-transcriptional control. At the cornerstone of post-transcriptional control lies RNA binding proteins (RBPs), which are involved in making decisions regarding whether a final product should be made and how, when and where this should occur in a cell. This research aims to use state-of-the-art screening to systematically identify RBPs that are required for HSCs to function properly and subsequently to identify by unbiased techniques how these RBPs control the HSC program. We anticipate the insights from this research can advance the clinical application of HSC transplants and inform the design of improved therapeutics for blood pathologies.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
383346
Name
Keyvani Chahi Ava
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Dissecting RNA binding protein-directed control over hematopoietic stem cells by CRISPR-based genetic screening
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Flow Cytometry; Genetic Screening; Hematopoietic Stem Cell; Mouse Models; Next-Generation Sequencing; Post-Transcriptional Control; Regenerative Medicine; Rna Binding Proteins; Systems-Level Molecular Biology
Abstract
Hematopoietic stem cells (HSCs) maintain an individual's life-time requirement of all the cells that compose the blood system. To achieve this HSCs must balance multiple functions, including the generation of functional blood and immune cells in appropriate frequencies and the enduring potential to recreate identical versions of itself (self-renew). Dysregulation of the balance that defines the HSC program largely underlies cancerous and non-cancerous blood pathologies. Often, HSC transplants are required, life-saving therapies. The success of transplants is limited by the scarcity of HSCs in donor bone marrow samples. As such, a major goal has been to expand functional HSCs prior to transplant. This has proven challenging due to our very limited understanding of the genetic and molecular mechanisms that control the HSC program. Molecular mechanisms depend on the molecules that exist and cooperate within a cell. Notably, genes in a cell are first turned on in the form of RNA molecules that undergo many decisions before they are turned into a final product, often a protein molecule. To date, much effort has been directed to understanding the first step when genes are turned on (transcribed) in HSCs. By contrast, very little is known of the specific decisions made to generate the final products in HSCs, a process termed post-transcriptional control. At the cornerstone of post-transcriptional control lies RNA binding proteins (RBPs), which are involved in making decisions regarding whether a final product should be made and how, when and where this should occur in a cell. This research aims to use state-of-the-art screening to systematically identify RBPs that are required for HSCs to function properly and subsequently to identify by unbiased techniques how these RBPs control the HSC program. We anticipate the insights from this research can advance the clinical application of HSC transplants and inform the design of improved therapeutics for blood pathologies.
Competitiondate
201710
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Keyvani Chahi, Ava
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~